Tech Company Financing Transactions
Mediwhale Funding Round
On 9/25/2024, Mediwhale announced $12 million in Series A funding from Korea Development Bank, IMM Investment and Mirae Asset Securities.
Transaction Overview
Company Name
Announced On
9/25/2024
Transaction Type
Venture Equity
Amount
$12,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to continue to enhance AI algorithms, achieve U.S. FDA approval for Reti-CVD, expand its global footprint, and develop new products to predict chronic kidney disease risk.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
37A Hongkong St
Singapore, 059676
SG
Singapore, 059676
SG
Phone
Undisclosed
Website
Email Address
Overview
We believe that early detection is the best prevention. Our innovative diagnostic technology helps you take action before symptoms appear. Our mission is to empower everyone to know their health risks early through a simple eye scan in a primary care setting.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Kevin Choi
Chief Medical Officer
Tyler Rim
Chief Operating Officer
Nina Shin
Chief Technical Officer
Young Lee
Browse more venture capital transactions:
Prev: 9/25/2024: Marvel Fusion venture capital transaction
Next: 9/25/2024: AminoChain venture capital transaction
Share this article
Where The Data Comes From
We report on all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs